Ustekinumab therapy improves the nutritional status in patients with Crohn's Disease. A prospective study

被引：0
|
作者：
Bertani, L. [1 ,2 ]
D'Alessandro, C. [1 ]
Fornili, M. [3 ]
Coppini, F. [1 ]
Zanzi, F. [1 ]
Carmisciano, L. [3 ]
Geri, F. [1 ]
Svizzero, G. Baiano [4 ]
Ceccarelli, L. [4 ]
机构：
[1] Univ Pisa, Translat Res & New Technol Med & Surg, Pisa, Italy
[2] Tuscany North West ASL Pontedera Hosp, Gen Surg & Gastroenterol, Pontedera, Italy
[3] Univ Pisa, Clin & Expt Med, Pisa, Italy
[4] Pisa Univ Hosp, Gen Surg & Gastroenterol, Pisa, Italy
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P678
引用
收藏
页码：810 / 810
页数：1
相关论文
共 50 条
  • [31] Oral health and Nutritional Status in Patients Affected with Parkinson's Disease.
    Shyam, A.
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2015, 44 : 218 - 218
  • [32] Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
    Sandborn, William J.
    Gasink, Christopher
    Gao, Long-Long
    Blank, Marion A.
    Johanns, Jewel
    Guzzo, Cynthia
    Sands, Bruce E.
    Hanauer, Stephen B.
    Targan, Stephan
    Rutgeerts, Paul
    Ghosh, Subrata
    de Villiers, Willem J. S.
    Panaccione, Remo
    Greenberg, Gordon
    Schreiber, Stefan
    Lichtiger, Simon
    Feagan, Brian G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (16): : 1519 - 1528
  • [33] Concentrations of Ustekinumab During Induction Therapy Associate With Remission in Patients With Crohn's Disease
    Soufflet, Ninon
    Boschetti, Gilles
    Roblin, Xavier
    Cuercq, Charlotte
    Williet, Nicolas
    Charlois, Anne-Laure
    Duclaux-Loras, Remi
    Danion, Pauline
    Mialon, Anne
    Faure, Mathias
    Paul, Stephane
    Flourie, Bernard
    Nancey, Stephane
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (12) : 2610 - 2612
  • [34] Advances in medical therapy for Crohn's disease.
    D'Haens G.
    Daperno M.
    Current Gastroenterology Reports, 2002, 4 (6) : 506 - 512
  • [35] Perianal Crohn's disease. Multidisciplinary therapy
    Kroesen, A. J.
    COLOPROCTOLOGY, 2019, 41 (01) : 30 - 33
  • [36] Ustekinumab Intravenous Reinduction Therapy Is Effective at Recapturing Response in Patients With Crohn's Disease
    Hudson, Joshua
    Barnes, Edward L.
    Herfarth, Hans
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S382 - S383
  • [37] Malignant melanoma during ustekinumab therapy of Crohn's disease
    Ehmann, Laura M.
    Tillack-Schreiber, Cornelia
    Brand, Stephan
    Wollenberg, Andreas
    INFLAMMATORY BOWEL DISEASES, 2012, 18 (01) : E199 - E200
  • [38] THE PHARMACOKINETICS OF USTEKINUMAB (STELARA®) WERE SIMILAR BETWEEN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND CROHN'S DISEASE.
    Yao, Z.
    Zhou, W.
    Ji, J.
    Rose, S.
    Fei, K.
    Zhou, H.
    Xu, Z.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S38 - S39
  • [39] Efficacy of infliximab therapy in pediatric patients with refractory Crohn's disease.
    Fleming, ZI
    Gremse, DA
    Crissinger, KD
    JOURNAL OF INVESTIGATIVE MEDICINE, 2004, 52 (01) : S269 - S269
  • [40] A snapshot of the nutritional status of Crohn's disease among adolescents in Brazil: a prospective cross-sectional study
    Prospero Cavalcante Costa, Camila Ortiz
    Carrilho, Flair Jose
    Nunes, Valeria Sutti
    Sipahi, Aytan Miranda
    Rodrigues, Maraci
    BMC GASTROENTEROLOGY, 2015, 15
12345